Company profile for Bioiberica

PharmaCompass

Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

Related CompaniesRelated Companies

About

Bioiberica is a global Life Science company with more than 45 years' experience in the production and development of molecules of high biological and therapeutic value for the pharmaceutical and nutraceutical industries. This specialisation positions Bioiberica among the leading Heparin API manufacturers and as a world reference of other biologically-derived APIs and scientifically backed nutraceutical ingredients for mobility, digestive health and skin & beauty. Through its vertically integrated supply chain, Bioiberica ensures the highest quality, safety and full traceability of its products, which are produced in Europe.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Av. Països Catalans 34, planta 2ª 08950 Esplugues de Llobregat, Barcelona
Telephone
Telephone
+34 934904908
Contact Info
Others

Maria Vilar
Strategic Marketing & Product Manager-Healthcare

Events

Webinars & Exhibitions

Default Event

CPhI North America

Not Confirmed

envelop Contact Supplier

CPhI North America

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-58493.pdf

    https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-75499.pdf

    https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-21170.pdf

    https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-6899.pdf

    https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-91262.pdf

    https://www.pharmacompass.com/pdf/party/content/bioiberica-party-content-39360.pdf

NEWS #PharmaBuzz

read-more
read-more

https://www.bioiberica.com/en/media/news/bioiberica/bioiberica-obtains-self-determined-gras-status-collavant-n2-native-type-ii-collagen-unlocking-new-opportunities-us

PRESS RELEASE
02 Jul 2024

https://www.bioiberica.com/en/media/news/heparina/ensuring-availability-medicines-all-key-we-are-part-critical-medicines-alliance

PRESS RELEASE
23 May 2024

https://www.bioiberica.com/en/media/news/healthcare/our-hyaluronic-acid-matrix-ingredient-dermial-demonstrates-unique-skin-glow-effect-randomized-clinical-trial

PRESS RELEASE
13 May 2024

https://www.bioiberica.com/en/media/news/bioiberica/bioiberica-we-engage-strategic-collaborations-lead-increased-innovation

PRESS RELEASE
23 Apr 2024

https://www.bioiberica.com/en/media/news/healthcare/women-only-clinical-study-reveals-our-collavant-n2-native-undenatured-type-ii-collagen-shows-joint-health-benefits-40-mg

PRESS RELEASE
08 Apr 2024

https://www.bioiberica.com/en/media/news/salud-vegetal/bioiberica-launches-new-probiotic-biostimulant-terra-sorb-symbiotic-optimization-fertilization

PRESS RELEASE
11 Mar 2024

CEP/COS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

Bioiberica

Registration Number : 302MF10020

Registrant's Address : C/Antic Cami de Tordera, 109-119, Palafolls, 08389 Barcelona, ​​Spain

Initial Date of Registration : 2020-01-31

Latest Date of Registration : 2021-10-21

Bioiberica Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Aim is to develop innovative multifunctional biomaterials to heal wounds using affordable EU-based manufacturing technologies.


Lead Product(s): Undisclosed

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Undisclosed

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 18, 2023

Bioiberica Company Banner

01

Bioiberica

Spain
arrow

Lead Product(s) : Undisclosed

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Aim is to develop innovative multifunctional biomaterials to heal wounds using affordable EU-based manufacturing technologies.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

January 18, 2023

Bioiberica Company Banner

Details:

By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient products across the country.


Lead Product(s): Undenatured Type II Collagen

Therapeutic Area: Musculoskeletal Brand Name: Collavant n2

Study Phase: Approved FDFProduct Type: Other Large Molecule

Sponsor: ByHealth

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership November 03, 2022

Bioiberica Company Banner

02

Bioiberica

Spain
arrow

Lead Product(s) : Undenatured Type II Collagen

Therapeutic Area : Musculoskeletal

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : ByHealth

Deal Size : Undisclosed

Deal Type : Partnership

Details : By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient produ...

Product Name : Collavant n2

Product Type : Other Large Molecule

Upfront Cash : Undisclosed

November 03, 2022

Bioiberica Company Banner

Details:

New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.


Lead Product(s): Hyaluronic Acid,Collagen,Dermatan Sulfate

Therapeutic Area: Dermatology Brand Name: Dermial

Study Phase: PreclinicalProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 25, 2022

Bioiberica Company Banner

03

Bioiberica

Spain
arrow

Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate

Therapeutic Area : Dermatology

Highest Development Status : Preclinical

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.

Product Name : Dermial

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

May 25, 2022

Bioiberica Company Banner

Details:

Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.


Lead Product(s): Chondroitin Sulfate Sodium

Therapeutic Area: Musculoskeletal Brand Name: CSbioactive

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 07, 2021

Bioiberica Company Banner

04

Bioiberica

Spain
arrow

Lead Product(s) : Chondroitin Sulfate Sodium

Therapeutic Area : Musculoskeletal

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.

Product Name : CSbioactive

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

May 07, 2021

Bioiberica Company Banner

Details:

Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint function.


Lead Product(s): Hyaluronic Acid,Type II Collagen

Therapeutic Area: Musculoskeletal Brand Name: Motilex HA

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Apsen

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership April 26, 2021

Bioiberica Company Banner

05

Bioiberica

Spain
arrow

Lead Product(s) : Hyaluronic Acid,Type II Collagen

Therapeutic Area : Musculoskeletal

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Apsen

Deal Size : Undisclosed

Deal Type : Partnership

Details : Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint...

Product Name : Motilex HA

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

April 26, 2021

Bioiberica Company Banner

Details:

B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.


Lead Product(s): Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid

Therapeutic Area: Musculoskeletal Brand Name: Collavant n2

Study Phase: Approved FDFProduct Type: Other Large Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 15, 2020

Bioiberica Company Banner

06

Bioiberica

Spain
arrow

Lead Product(s) : Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid

Therapeutic Area : Musculoskeletal

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.

Product Name : Collavant n2

Product Type : Other Large Molecule

Upfront Cash : Inapplicable

July 15, 2020

Bioiberica Company Banner

Details:

The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract rich in hyaluronic acid.


Lead Product(s): Undenatured Type II Collagen,Chondroitin Sulfate Sodium,Hyaluronic Acid

Therapeutic Area: Musculoskeletal Brand Name: Collavant n2

Study Phase: Approved FDFProduct Type: Other Large Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 09, 2020

Bioiberica Company Banner

07

Bioiberica

Spain
arrow

Lead Product(s) : Undenatured Type II Collagen,Chondroitin Sulfate Sodium,Hyaluronic Acid

Therapeutic Area : Musculoskeletal

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract ...

Product Name : Collavant n2

Product Type : Other Large Molecule

Upfront Cash : Inapplicable

July 09, 2020

Bioiberica Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KEY PRODUCTS

read-more
read-more

TOP RANKED SUPPLIER FOR:

Sponsored Ads.
full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view
Sponsored Ads.full-view

Excipients

Discover the DDS // excipients from this company

All Excipients

read-more
read-more

01

Chondroitin Sulfate Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
Bioiberica Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Check the inspections & registration from this company

ABOUT THIS PAGE

Contact Bioiberica and get a quotation

Bioiberica is a supplier offers 12 products (APIs, Excipients or Intermediates).

Find a price of Heparin Sodium bulk with DMF, JDMF offered by Bioiberica

Find a price of Chondroitin Sulfate Sodium bulk with CEP offered by Bioiberica

Find a price of Heparin Sodium bulk with DMF offered by Bioiberica

Find a price of Chondroitin Sulfate Sodium bulk offered by Bioiberica

Find a price of Glucosamine bulk offered by Bioiberica

Find a price of Glucosamine Hydrochloride bulk offered by Bioiberica

Find a price of Glucosamine Sulfate Potassium Chloride bulk offered by Bioiberica

Find a price of Glucosamine Sulfate Sodium Chloride bulk offered by Bioiberica

Find a price of Heparin Lithium bulk offered by Bioiberica

Find a price of Levothyroxine Sodium bulk offered by Bioiberica

Find a price of Liothyronine Sodium bulk offered by Bioiberica

Find a price of Thyroid bulk offered by Bioiberica

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty